To assess the association between maternal SARS-CoV-2 infection during pregnancy and neonatal congenital anomalies, highlighting its public health implications.
Key Findings:
1.4 additional congenital anomalies per 1000 live births in the SARS-CoV-2 infection cohort compared to the uninfected cohort, not statistically significant.
Rate ratio for congenital anomalies was 1.04 (95% CI, 0.87-1.24), indicating no significant difference.
Rate ratio for cardiac anomalies was 1.22 (95% CI, 0.88-1.66), also not statistically significant.
Interpretation:
While the study suggests a potential association between maternal SARS-CoV-2 infection and congenital anomalies, the results do not reach statistical significance, necessitating further investigation and consideration for clinical practice.
Limitations:
Potential misclassification of asymptomatic SARS-CoV-2 infections in the control group.
Exclusion of stillbirths may bias results.
Statistical significance not achieved despite point estimates suggesting increased risk, potentially influenced by sample size.
Conclusion:
Further research is required to clarify the relationship between maternal SARS-CoV-2 infection and congenital anomalies, with current evidence supporting continued vaccination recommendations for pregnant individuals and emphasizing the need for ongoing investigation.
